PMID: 11320034Apr 26, 2001Paper

Canalicular stenosis secondary to docetaxel (taxotere): a newly recognized side effect

Ophthalmology
B EsmaeliD Booser

Abstract

To report a newly recognized side effect of a commonly used antineoplastic agent, docetaxel, in three patients with metastatic breast cancer. Observational case reports. Three patients with metastatic breast cancer who received weekly docetaxel chemotherapy. Occurrence of epiphora and severity of punctal and canalicular fibrosis secondary to docetaxel. In three patients receiving weekly docetaxel, canalicular stenosis and resultant epiphora developed shortly after start of their treatment. Discontinuation of drug several months after initiation of therapy did not lead to resolution of symptoms in two of the three patients. Epiphora is a newly recognized side effect of docetaxel and may occur more frequently with weekly cycles of this drug. The mechanism for epiphora seems to be punctal and canalicular stenosis. This side effect, in advanced cases, is not reversible with discontinuation of the drug. Patients being administered weekly cycles of docetaxel should be screened for epiphora and canalicular stenosis, and treatment in the form of silicone intubation or punctoplasty should be considered in early stages to prevent the need for conjunctivodacryocystorhinostomy.

References

May 1, 1978·Annals of Internal Medicine·D J HaidakK Y Yeung
Dec 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·V ValeroG N Hortobagyi
Mar 15, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H J BursteinE P Winer
Apr 25, 2000·American Journal of Clinical Oncology·V FerraresiF Cognetti
Jul 2, 2005·Expert Opinion on Investigational Drugs·P FumoleauW W Ten Bokkel Huinink

❮ Previous
Next ❯

Citations

Feb 7, 2002·Pharmacoepidemiology and Drug Safety
Jan 15, 2003·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Katsumasa KuroiMasakazu Toi
Mar 11, 2006·Cancer Chemotherapy and Pharmacology·Hugo E R FordStephen R D Johnston
Dec 4, 2003·American Journal of Ophthalmology·Mohsen Bahmani KashkouliNick Astbury
Apr 4, 2007·Prostate Cancer and Prostatic Diseases·S GuptaD L Trump
Mar 12, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B EsmaeliR Arbuckle
Jul 23, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B LeyssensI Mombaerts
May 17, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N KimK-W Lee
Apr 15, 2003·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Bruce A Teitelbaum, David J Tresley
Oct 19, 2004·The British Journal of Ophthalmology·E Dafgård Kopp, S Seregard
May 5, 2006·The British Journal of Ophthalmology·J J Khong, J Muecke
Aug 1, 2012·Clinical Ophthalmology·Uri SoibermanIgal Leibovitch
Feb 10, 2010·Middle East African Journal of Ophthalmology·Amal Bukhari
Mar 13, 2014·Ophthalmic Plastic and Reconstructive Surgery·Rachel K SobelRichard C Allen
Sep 21, 2013·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Sara Abu-GhanemAvraham Abergel
Apr 16, 2003·Eye & Contact Lens·Craig A Skolnick, Donald J Doughman
Sep 28, 2010·Ophthalmic Plastic and Reconstructive Surgery·Christopher I ZoumalanRichard D Lisman
Feb 2, 2011·Ophthalmic Plastic and Reconstructive Surgery·Altuğ CetinkayaDwight Kulwin
Apr 5, 2013·Ophthalmic Plastic and Reconstructive Surgery·Alexander D PortGary J Lelli
Dec 9, 2010·The American Journal of the Medical Sciences·Preston H Blomquist
Jan 20, 2007·Journal of Biomedical Materials Research. Part a·Mi YangBaorui Liu
Feb 20, 2007·Acta Ophthalmologica Scandinavica·Sanj WickremasingheClare Davey
May 24, 2006·Pharmacotherapy·Polly E KintzelMarianne K Lange
Dec 1, 2005·Expert Opinion on Pharmacotherapy·Pedro F Escobar, Peter G Rose
May 24, 2012·Orbit·Claire E FraserGary J Lelli
Oct 19, 2010·Cutaneous and Ocular Toxicology·James Fen Taye Li Yim, Kevin P Crofts
Jul 19, 2016·Ophthalmic Plastic and Reconstructive Surgery·Constanza MansurBita Esmaeli
May 8, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bita Esmaeli, Vicente Valero
Aug 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bita EsmaeliEdgardo Rivera
Mar 4, 2017·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Namju KimKeun-Wook Lee
Aug 16, 2003·Ophthalmic Plastic and Reconstructive Surgery·Andrew S EisemanClifford H Pemberton
Jul 25, 2003·Ophthalmic Plastic and Reconstructive Surgery·Bita EsmaeliVictor G Prieto
Apr 15, 2004·Ophthalmic Plastic and Reconstructive Surgery·J A BurnsR T Kloos
Mar 29, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Francisco J EstevaGabriel N Hortobagyi
Mar 28, 2017·The British Journal of Ophthalmology·Sunah KangHo-Seok Sa
Apr 7, 2007·Ophthalmic Plastic and Reconstructive Surgery·Emily McCartneyRichard Burgett

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.